Predictive models for response and survival in patients treated with anti-PD-1 monotherapy or with anti-PD-1 and ipilimumab combination: editorial commentary-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictive models for response and survival in patients treated with anti-PD-1 monotherapy or with anti-PD-1 and ipilimumab combination: editorial commentary

Published:2023-03 Issue:5 Volume:11 Page:227-227
ISSN:2305-5839
Container-title:Annals of Translational Medicine
language:
Short-container-title:Ann Transl Med

Author:

Rotte Anand

Publisher

AME Publishing Company

Subject

General Medicine

Link

https://atm.amegroups.com/article/download/108716/pdf

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Cell and Gene Therapies for Clinical Use in the US and EU: Summary of Regulatory Guidelines;Current Gene Therapy;2025-02

2. Tumor cells inhibit the activation of ILC2s through up-regulating PD-1 expression;Immunopharmacology and Immunotoxicology;2024-05-03

3. Editorial: Emerging learnings in cell therapy: novel binding domains, universal CAR-T cells, and more;Frontiers in Oncology;2024-04-15

4. Postoperative adjuvant immunotherapy for high-risk hepatocellular carcinoma patients;Frontiers in Oncology;2023-12-15

5. Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers;Journal of Experimental & Clinical Cancer Research;2023-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP